CHAMPIONS ONCOLOGY, INC. (CSBR) › Cash & EquivalentsCHAMPIONS ONCOLOGY, INC. (CSBR) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $2.57M2011: $10.46M2012: $4.75M2013: $9.56M2014: $5.89M2015: $9.36M2016: $2.58M2017: $3.29M2018: $856.0K2019: $3.24M$3.24M2010Cash & Equivalents (USD)2019Fiscal YearCash & EquivalentsChange YoY2019$3.24M+278.2%2018$856.0K-74.0%2017$3.29M+27.5%2016$2.58M-72.4%2015$9.36M+58.8%2014$5.89M-38.4%2013$9.56M+101.1%2012$4.75M-54.5%2011$10.46M+306.6%2010$2.57M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share